Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

Scope of the Report:
The classification of Flu Vaccine includes Whole Virus Vaccines, Split Virus Vaccines, Subunit Vaccines and Live Attenuated Virus Vaccines, and the proportion of Whole Virus Vaccines in 2016 is about 43%, and the proportion is in decreasing trend from 2012 to 2016.
Flu Vaccine is widely used for Children (6 months to 3 years) and for Adults and Children over 3 years. The most proportion of Flu Vaccine is For Adults and Children over 3 years, and the proportion in 2016 is about 75%.
The Europe in the EMEA is the largest consumption place, with a consumption market share nearly 80% in 2016. And in the major countries we mentioned in the report, Germany is the largest consumption place with the consumption market share of 12%. Following Russia, France is the second largest consumption region, with the proportion of 11%.
The worldwide market for Flu Vaccine (Influenza Vaccine) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new WMR study.
This report focuses on the Flu Vaccine (Influenza Vaccine) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson & Johnson

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Whole Virus Vaccines
Split Virus Vaccines
Subunit Vaccines
Live Attenuated Virus Vaccines

Market Segment by Applications, can be divided into
For Children (6 months to 3 years)
For Adults and Children over 3 years

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Flu Vaccine (Influenza Vaccine) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Flu Vaccine (Influenza Vaccine), with price, sales, revenue and global market share of Flu Vaccine (Influenza Vaccine) in 2017 and 2018.
Chapter 3, the Flu Vaccine (Influenza Vaccine) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Flu Vaccine (Influenza Vaccine) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Flu Vaccine (Influenza Vaccine) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Flu Vaccine (Influenza Vaccine) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
1.1 Flu Vaccine (Influenza Vaccine) Introduction
1.2 Market Analysis by Type
1.2.1 Whole Virus Vaccines
1.2.2 Split Virus Vaccines
1.2.3 Subunit Vaccines
1.2.4 Live Attenuated Virus Vaccines
1.3 Market Analysis by Applications
1.3.1 For Children (6 months to 3 years)
1.3.2 For Adults and Children over 3 years
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 CSL
2.1.1 Business Overview
2.1.2 Flu Vaccine (Influenza Vaccine) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 CSL Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 GSK
2.2.1 Business Overview
2.2.2 Flu Vaccine (Influenza Vaccine) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GSK Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Sanofi Pasteur
2.3.1 Business Overview
2.3.2 Flu Vaccine (Influenza Vaccine) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Mylan
2.4.1 Business Overview
2.4.2 Flu Vaccine (Influenza Vaccine) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Mylan Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 AstraZeneca
2.5.1 Business Overview
2.5.2 Flu Vaccine (Influenza Vaccine) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AstraZeneca Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Pfizer
2.6.1 Business Overview
2.6.2 Flu Vaccine (Influenza Vaccine) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Pfizer Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Johnson & Johnson
2.7.1 Business Overview
2.7.2 Flu Vaccine (Influenza Vaccine) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Johnson & Johnson Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Flu Vaccine (Influenza Vaccine) Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Flu Vaccine (Influenza Vaccine) Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Flu Vaccine (Influenza Vaccine) Manufacturer Market Share in 2018
3.3.2 Top 6 Flu Vaccine (Influenza Vaccine) Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Flu Vaccine (Influenza Vaccine) Market Analysis by Regions
4.1 Global Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Regions
4.1.1 Global Flu Vaccine (Influenza Vaccine) Sales and Market Share by Regions (2014-2019)
4.1.2 Global Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Regions (2014-2019)
4.2 North America Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
4.3 Europe Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
4.5 South America Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
5 North America Flu Vaccine (Influenza Vaccine) by Country
5.1 North America Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Country
5.1.1 North America Flu Vaccine (Influenza Vaccine) Sales and Market Share by Country (2014-2019)
5.1.2 North America Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Country (2014-2019)
5.2 United States Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
5.3 Canada Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
5.4 Mexico Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
6 Europe Flu Vaccine (Influenza Vaccine) by Country
6.1 Europe Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Country
6.1.1 Europe Flu Vaccine (Influenza Vaccine) Sales and Market Share by Country (2014-2019)
6.1.2 Europe Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Country (2014-2019)
6.2 Germany Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
6.3 UK Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
6.4 France Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
6.5 Russia Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
6.6 Italy Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
7 Asia-Pacific Flu Vaccine (Influenza Vaccine) by Country
7.1 Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Country (2014-2019)
7.2 China Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
7.3 Japan Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
7.4 Korea Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
7.5 India Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
8 South America Flu Vaccine (Influenza Vaccine) by Country
8.1 South America Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Country
8.1.1 South America Flu Vaccine (Influenza Vaccine) Sales and Market Share by Country (2014-2019)
8.1.2 South America Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Country (2014-2019)
8.2 Brazil Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
8.3 Argentina Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
8.4 Colombia Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
9 Middle East and Africa Flu Vaccine (Influenza Vaccine) by Countries
9.1 Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
9.3 Turkey Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
9.4 Egypt Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
9.5 Nigeria Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
9.6 South Africa Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
10 Global Flu Vaccine (Influenza Vaccine) Market Segment by Type
10.1 Global Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Flu Vaccine (Influenza Vaccine) Sales and Market Share by Type (2014-2019)
10.1.2 Global Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Type (2014-2019)
10.2 Whole Virus Vaccines Sales Growth and Price
10.2.1 Global Whole Virus Vaccines Sales Growth (2014-2019)
10.2.2 Global Whole Virus Vaccines Price (2014-2019)
10.3 Split Virus Vaccines Sales Growth and Price
10.3.1 Global Split Virus Vaccines Sales Growth (2014-2019)
10.3.2 Global Split Virus Vaccines Price (2014-2019)
10.4 Subunit Vaccines Sales Growth and Price
10.4.1 Global Subunit Vaccines Sales Growth (2014-2019)
10.4.2 Global Subunit Vaccines Price (2014-2019)
10.5 Live Attenuated Virus Vaccines Sales Growth and Price
10.5.1 Global Live Attenuated Virus Vaccines Sales Growth (2014-2019)
10.5.2 Global Live Attenuated Virus Vaccines Price (2014-2019)
11 Global Flu Vaccine (Influenza Vaccine) Market Segment by Application
11.1 Global Flu Vaccine (Influenza Vaccine) Sales Market Share by Application (2014-2019)
11.2 For Children (6 months to 3 years) Sales Growth (2014-2019)
11.3 For Adults and Children over 3 years Sales Growth (2014-2019)
12 Flu Vaccine (Influenza Vaccine) Market Forecast (2019-2024)
12.1 Global Flu Vaccine (Influenza Vaccine) Sales, Revenue and Growth Rate (2019-2024)
12.2 Flu Vaccine (Influenza Vaccine) Market Forecast by Regions (2019-2024)
12.2.1 North America Flu Vaccine (Influenza Vaccine) Market Forecast (2019-2024)
12.2.2 Europe Flu Vaccine (Influenza Vaccine) Market Forecast (2019-2024)
12.2.3 Asia-Pacific Flu Vaccine (Influenza Vaccine) Market Forecast (2019-2024)
12.2.4 South America Flu Vaccine (Influenza Vaccine) Market Forecast (2019-2024)
12.2.5 Middle East and Africa Flu Vaccine (Influenza Vaccine) Market Forecast (2019-2024)
12.3 Flu Vaccine (Influenza Vaccine) Market Forecast by Type (2019-2024)
12.3.1 Global Flu Vaccine (Influenza Vaccine) Sales Forecast by Type (2019-2024)
12.3.2 Global Flu Vaccine (Influenza Vaccine) Market Share Forecast by Type (2019-2024)
12.4 Flu Vaccine (Influenza Vaccine) Market Forecast by Application (2019-2024)
12.4.1 Global Flu Vaccine (Influenza Vaccine) Sales Forecast by Application (2019-2024)
12.4.2 Global Flu Vaccine (Influenza Vaccine) Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source


List of Tables and Figures

Figure Flu Vaccine (Influenza Vaccine) Picture
Table Product Specifications of Flu Vaccine (Influenza Vaccine)
Figure Global Sales Market Share of Flu Vaccine (Influenza Vaccine) by Types in 2018
Table Flu Vaccine (Influenza Vaccine) Types for Major Manufacturers
Figure Whole Virus Vaccines Picture
Figure Split Virus Vaccines Picture
Figure Subunit Vaccines Picture
Figure Live Attenuated Virus Vaccines Picture
Figure Flu Vaccine (Influenza Vaccine) Sales Market Share by Applications in 2018
Figure For Children (6 months to 3 years) Picture
Figure For Adults and Children over 3 years Picture
Figure United States Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2014-2024)
Figure France Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2014-2024)
Figure UK Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2014-2024)
Figure China Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2014-2024)
Figure India Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Flu Vaccine (Influenza Vaccine) Revenue (Value) and Growth Rate (2014-2024)
Table CSL Basic Information, Manufacturing Base and Competitors
Table CSL Flu Vaccine (Influenza Vaccine) Type and Applications
Table CSL Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Flu Vaccine (Influenza Vaccine) Type and Applications
Table GSK Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Type and Applications
Table Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Flu Vaccine (Influenza Vaccine) Type and Applications
Table Mylan Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Flu Vaccine (Influenza Vaccine) Type and Applications
Table AstraZeneca Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Flu Vaccine (Influenza Vaccine) Type and Applications
Table Pfizer Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Flu Vaccine (Influenza Vaccine) Type and Applications
Table Johnson & Johnson Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Flu Vaccine (Influenza Vaccine) Sales by Manufacturer (2017-2018)
Figure Global Flu Vaccine (Influenza Vaccine) Sales Market Share by Manufacturer in 2017
Figure Global Flu Vaccine (Influenza Vaccine) Sales Market Share by Manufacturer in 2018
Table Global Flu Vaccine (Influenza Vaccine) Revenue by Manufacturer (2017-2018)
Figure Global Flu Vaccine (Influenza Vaccine) Revenue Market Share by Manufacturer in 2017
Figure Global Flu Vaccine (Influenza Vaccine) Revenue Market Share by Manufacturer in 2018
Figure Top 3 Flu Vaccine (Influenza Vaccine) Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Flu Vaccine (Influenza Vaccine) Manufacturer (Revenue) Market Share in 2018
Figure Global Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
Figure Global Flu Vaccine (Influenza Vaccine) Revenue and Growth Rate (2014-2019)
Table Global Flu Vaccine (Influenza Vaccine) Sales by Regions (2014-2019)
Table Global Flu Vaccine (Influenza Vaccine) Sales Market Share by Regions (2014-2019)
Table Global Flu Vaccine (Influenza Vaccine) Revenue by Regions (2014-2019)
Figure Global Flu Vaccine (Influenza Vaccine) Revenue Market Share by Regions in 2014
Figure Global Flu Vaccine (Influenza Vaccine) Revenue Market Share by Regions in 2018
Figure North America Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
Figure Europe Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
Figure South America Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
Figure North America Flu Vaccine (Influenza Vaccine) Revenue and Growth Rate (2014-2019)
Table North America Flu Vaccine (Influenza Vaccine) Sales by Countries (2014-2019)
Table North America Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries (2014-2019)
Figure North America Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries in 2014
Figure North America Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries in 2018
Table North America Flu Vaccine (Influenza Vaccine) Revenue by Countries (2014-2019)
Table North America Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries (2014-2019)
Figure North America Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries in 2014
Figure North America Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries in 2018
Figure United States Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
Figure Canada Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
Figure Mexico Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
Figure Europe Flu Vaccine (Influenza Vaccine) Revenue and Growth Rate (2014-2019)
Table Europe Flu Vaccine (Influenza Vaccine) Sales by Countries (2014-2019)
Table Europe Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries (2014-2019)
Table Europe Flu Vaccine (Influenza Vaccine) Revenue by Countries (2014-2019)
Figure Europe Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries in 2017
Figure Europe Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries in 2018
Figure Germany Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
Figure UK Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
Figure France Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
Figure Russia Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
Figure Italy Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Flu Vaccine (Influenza Vaccine) Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales by Countries (2014-2019)
Table Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries 2018
Table Asia-Pacific Flu Vaccine (Influenza Vaccine) Revenue by Countries (2014-2019)
Figure Asia-Pacific Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries 2018
Figure China Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
Figure Japan Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
Figure Korea Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
Figure India Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
Figure Southeast Asia Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
Figure South America Flu Vaccine (Influenza Vaccine) Revenue and Growth Rate (2014-2019)
Table South America Flu Vaccine (Influenza Vaccine) Sales by Countries (2014-2019)
Table South America Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries (2014-2019)
Figure South America Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries in 2018
Table South America Flu Vaccine (Influenza Vaccine) Revenue by Countries (2014-2019)
Table South America Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries (2014-2019)
Figure South America Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries in 2018
Figure Brazil Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
Figure Argentina Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
Figure Colombia Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales by Countries (2014-2019)
Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries in 2018
Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue by Countries (2014-2019)
Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries in 2014
Figure Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries in 2018
Figure Saudi Arabia Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
Figure UAE Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
Figure Egypt Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
Figure Nigeria Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
Figure South Africa Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
Table Global Flu Vaccine (Influenza Vaccine) Sales by Type (2014-2019)
Table Global Flu Vaccine (Influenza Vaccine) Sales Share by Type (2014-2019)
Table Global Flu Vaccine (Influenza Vaccine) Revenue by Type (2014-2019)
Table Global Flu Vaccine (Influenza Vaccine) Revenue Share by Type (2014-2019)
Figure Global Whole Virus Vaccines Sales Growth (2014-2019)
Figure Global Whole Virus Vaccines Price (2014-2019)
Figure Global Split Virus Vaccines Sales Growth (2014-2019)
Figure Global Split Virus Vaccines Price (2014-2019)
Figure Global Subunit Vaccines Sales Growth (2014-2019)
Figure Global Subunit Vaccines Price (2014-2019)
Figure Global Live Attenuated Virus Vaccines Sales Growth (2014-2019)
Figure Global Live Attenuated Virus Vaccines Price (2014-2019)
Table Global Flu Vaccine (Influenza Vaccine) Sales by Application (2014-2019)
Table Global Flu Vaccine (Influenza Vaccine) Sales Share by Application (2014-2019)
Figure Global For Adults and Children over 3 years Sales Growth (2014-2019)
Figure Global Flu Vaccine (Influenza Vaccine) Sales, Revenue and Growth Rate (2019-2024)
Table Global Flu Vaccine (Influenza Vaccine) Sales Forecast by Regions (2019-2024)
Table Global Flu Vaccine (Influenza Vaccine) Market Share Forecast by Regions (2019-2024)
Figure North America Sales Flu Vaccine (Influenza Vaccine) Market Forecast (2019-2024)
Figure Europe Sales Flu Vaccine (Influenza Vaccine) Market Forecast (2019-2024)
Figure Asia-Pacific Sales Flu Vaccine (Influenza Vaccine) Market Forecast (2019-2024)
Figure South America Sales Flu Vaccine (Influenza Vaccine) Market Forecast (2019-2024)
Figure Middle East and Africa Sales Flu Vaccine (Influenza Vaccine) Market Forecast (2019-2024)
Table Global Flu Vaccine (Influenza Vaccine) Sales Forecast by Type (2019-2024)
Table Global Flu Vaccine (Influenza Vaccine) Market Share Forecast by Type (2019-2024)
Table Global Flu Vaccine (Influenza Vaccine) Sales Forecast by Application (2019-2024)
Table Global Flu Vaccine (Influenza Vaccine) Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List

Global Cold Chain Equipment Market (2024 Edition): Analysis By Equipment Type (Refrigerators, Deep Freezers & Reefer Containers, Cold Boxes & Vaccine Carriers, Cold Rooms/ Chillers, Other Equipment Types), By Purpose, By End-use, By Region, By Country: Market Insights and Forecast (2020-2030)...

Executive Summary Azoth Analytics has released a research report titled "Global Cold Chain Equipment Market (2024 Edition)" which provides a complete analysis of the Global Cold Chain Equipment market in terms of market segmentation By Equipment Type (Refrigerators, Deep Freezers & Reef...

Global Vaccine Supply Chain Solutions Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Vaccine Supply Chain Solutions Market: The report discusses everything a marketer requires before investing in the global Vaccine Supply Chain Solutions Market during the forecast period 2023-...

Global Digital Vaccine Tracking System Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Digital Vaccine Tracking System Market: The report discusses everything a marketer requires before investing in the global Digital Vaccine Tracking System Market during the forecast period 202...

Asia Pacific Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

Asia Pacific preventive vaccines market will grow by 7.9% annually with a total addressable market cap of $217.46 billion over 2023-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for p...

Europe Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

Europe preventive vaccines market was valued at $18.02 billion in 2022 and will grow by 5.1% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines s...

North America Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

North America preventive vaccines market is projected to grow by 6.3% annually in the forecast period and reach $46.90 billion by 2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for pre...

Global Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Region: Trend Forecast and Growth Opportunity...

Global preventive vaccines market will reach $120.07 billion by 2032, growing by 6.4% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines such as ...

2023-2028 Global and Regional Rapid Influenza Diagnostic Test (RIDT) Industry Status and Prospects Professional Market Research Report Standard Version...

The global Rapid Influenza Diagnostic Test (RIDT) market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help mark...

2023-2028 Global and Regional Whole Cell Cholera Vaccine Industry Status and Prospects Professional Market Research Report Standard Version...

The global Whole Cell Cholera Vaccine market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players i...

2023-2028 Global and Regional Viral Vaccine Media Industry Status and Prospects Professional Market Research Report Standard Version...

The global Viral Vaccine Media market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this ...